{
    "N/R/U": null,
    "Applicant": "Sanofi-Aventis U.S. LLC",
    "BLA Number": "761325",
    "Proprietary Name": "Merilog",
    "Proper Name": "insulin aspart-szjj",
    "BLA Type": "351(k) Biosimilar",
    "Strength": "1,000UNITS/10ML (100UNITS/ML)",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Multi-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "February 14, 2025",
    "Ref. Product Proper Name": "insulin aspart",
    "Ref. Product Proprietary Name": "Novolog",
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "1752",
    "Product Number": "001",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "insulin aspart-szjj",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_145810"
        }
    ]
}